851 research outputs found
Glucose-Insulin-Potassium Therapy Guided by a Glucose-Controlled Insulin Infusion System in Acute Myocardinal Infarction
A Very Intense Neutrino Super Beam Experiment for Leptonic CP Violation Discovery based on the European Spallation Source Linac: A Snowmass 2013 White Paper
Very intense neutrino beams and large neutrino detectors will be needed in
order to enable the discovery of CP violation in the leptonic sector. We
propose to use the proton linac of the European Spallation Source currently
under construction in Lund, Sweden to deliver, in parallel with the spallation
neutron production, a very intense, cost effective and high performance
neutrino beam. The baseline program for the European Spallation Source linac is
that it will be fully operational at 5 MW average power by 2022, producing 2
GeV 2.86 ms long proton pulses at a rate of 14 Hz. Our proposal is to upgrade
the linac to 10 MW average power and 28 Hz, producing 14 pulses/s for neutron
production and 14 pulses/s for neutrino production. Furthermore, because of the
high current required in the pulsed neutrino horn, the length of the pulses
used for neutrino production needs to be compressed to a few s with the
aid of an accumulator ring. A long baseline experiment using this Super Beam
and a megaton underground Water Cherenkov detector located in existing mines
300-600 km from Lund will make it possible to discover leptonic CP violation at
5 significance level in up to 50% of the leptonic Dirac CP-violating
phase range. This experiment could also determine the neutrino mass hierarchy
at a significance level of more than 3 if this issue will not already
have been settled by other experiments by then. The mass hierarchy performance
could be increased by combining the neutrino beam results with those obtained
from atmospheric neutrinos detected by the same large volume detector. This
detector will also be used to measure the proton lifetime, detect cosmological
neutrinos and neutrinos from supernova explosions. Results on the sensitivity
to leptonic CP violation and the neutrino mass hierarchy are presented.Comment: 28 page
Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation.
BACKGROUND
Atrial fibrillation (AF) is associated with cognitive dysfunction. However, neurocognitive function in AF patients undergoing pulmonary vein isolation (PVI) has not been well studied. The aim of this analysis is to compare neurocognitive function in patients who did or did not undergo PVI.
MATERIALS AND METHODS
We used data from the Swiss Atrial Fibrillation Cohort study (Swiss-AF), a prospective, observational, multicenter study in Switzerland. Patients with documented AF were enrolled and data of 1,576 patients without history of PVI and with complete information on PVI status and neurocognitive function were used. Information on PVI was collected at baseline and during 1 year of follow-up. Neurocognitive testing was performed at baseline and after 1 year of follow-up, using the Montreal Cognitive Assessment (MoCA), trail making test (TMT) A and B, digit symbol substitution test (DSST) and semantic fluency test (SFT). To investigate the association of PVI with neurocognitive function, we use propensity score matching (1:3) and inverse probability of treatment weighting (IPTW).
RESULTS
The mean age of this population was 74 ± 8 years, 27.1% were women. Overall, 88 (5.5%) patients underwent PVI during 1 year of follow-up. Using ITPW (n = 1576), PVI was weakly associated with the MoCA score after adjusting for time since PVI, baseline MoCA score and other covariates (ÎČ (95%CI) 1.19 (0.05; 2.32), p = 0.04). In the propensity matched comparison (n = 352), there was no significant association between PVI and the MoCA score (ÎČ (95%CI) 1.04 (-0.19; 2.28), p = 0.1). There were no significant associations between PVI and cognitive function when using the TMT A and B, DSST or SFT independent of the method used.
CONCLUSION
In this population of AF patients, there was no consistent evidence of an association between PVI and neurocognitive function.
CLINICAL TRIAL REGISTRATION
[https://clinicaltrials.gov/], identifier [NCT02105844]
Semi-Dense 3D Reconstruction with a Stereo Event Camera
Event cameras are bio-inspired sensors that offer several advantages, such as
low latency, high-speed and high dynamic range, to tackle challenging scenarios
in computer vision. This paper presents a solution to the problem of 3D
reconstruction from data captured by a stereo event-camera rig moving in a
static scene, such as in the context of stereo Simultaneous Localization and
Mapping. The proposed method consists of the optimization of an energy function
designed to exploit small-baseline spatio-temporal consistency of events
triggered across both stereo image planes. To improve the density of the
reconstruction and to reduce the uncertainty of the estimation, a probabilistic
depth-fusion strategy is also developed. The resulting method has no special
requirements on either the motion of the stereo event-camera rig or on prior
knowledge about the scene. Experiments demonstrate our method can deal with
both texture-rich scenes as well as sparse scenes, outperforming
state-of-the-art stereo methods based on event data image representations.Comment: 19 pages, 8 figures, Video: https://youtu.be/Qrnpj2FD1e
Validation of a clinical model for predicting left versus right ventricular outflow tract origin of idiopathic ventricular arrhythmias.
BACKGROUND
Prediction of the chamber of origin in patients with outflow tract ventricular arrhythmias (OTVA) remains challenging. A clinical risk score based on age, sex and presence of hypertension was associated with a left ventricular outflow tract (LVOT) origin. We aimed to validate this clinical score to predict an LVOT origin in patients with OTVA.
METHODS
In a two-center observational cohort study, unselected patients undergoing catheter ablation (CA) for OTVA were enrolled. All procedures were performed using an electroanatomical mapping system. Successful ablation was defined as a â„80% reduction of the initial overall PVC burden after 3 months of follow-up. Patients with unsuccessful ablation were excluded from this analysis.
RESULTS
We included 187 consecutive patients with successful CA of idiopathic OTVA. Mean age was 52 ± 15 years, 102 patients (55%) were female, and 74 (40%) suffered from hypertension. A LVOT origin was found in 64 patients (34%). A score incorporating age, sex and presence of hypertension reached 73% sensitivity and 67% specificity for a low (0-1) and high (2-3) score, to predict an LVOT origin. The combination of one ECG algorithm (V2 S/V3 R-index) with the clinical score resulted in a sensitivity and specificity of 81% and 70% for PVCs with R/S transition at V3 .
CONCLUSION
The published clinical score yielded a lower sensitivity and specificity in our cohort. However, for PVCs with R/S transition at V3, the combination with an existing ECG algorithm can improve the predictability of LVOT origin
Physical activity and brain health in patients with atrial fibrillation
Background and purpose: Vascular brain lesions, such as ischemic infarcts, are common among patients with atrial fibrillation (AF) and are associated with impaired cognitive function. The role of physical activity (PA) in the prevalence of brain lesions and cognition in AF has not been investigated.
Methods: Patients from the multicenter SwissâAF cohort study were included in this crossâsectional analysis. We assessed regular exercise (RE; at least once weekly) and minutes of weekly PA using a validated questionnaire. We studied associations with ischemic infarcts, white matter hyperintensities, cerebral microbleeds, and brain volume on brain magnetic resonance imaging and with global cognition measured with a cognitive construct (CoCo) score.ResultsAmong 1490 participants (mean age = 72â±â9âyears), 730 (49%) engaged in RE. In adjusted regression analyses, RE was associated with a lower prevalence of ischemic infarcts (odds ratio [OR] =â0.78, 95% confidence interval [CI] =â0.63â0.98, p =â0.03) and of moderate to severe white matter hyperintensities (OR = 0.78, 95% CI = 0.62â0.99, p =â0.04), higher brain volume (ÎČâcoefficient = 10.73, 95% CI = 2.37â19.09, p =â0.01), and higher CoCo score (ÎČâcoefficient = 0.08, 95% CI = 0.03â0.12, p <â0.001). Increasing weekly PA was associated with higher brain volume (ÎČâcoefficient = 1.40, 95% CI = 0.65â2.15, p <â0.001).
Conclusions: In AF patients, RE was associated with a lower prevalence of ischemic infarcts and of moderate to severe white matter disease, with larger brain volume, and with better cognitive performance. Prospective studies are needed to investigate whether these associations are causal. Until then, our findings suggest that patients with AF should be encouraged to remain physically active
Mid-term changes in cognitive functions in patients with atrial fibrillation: a longitudinal analysis of the Swiss-AF cohort.
BACKGROUND
Longitudinal association studies of atrial fibrillation (AF) and cognitive functions have shown an unclear role of AF-type and often differ in methodological aspects. We therefore aim to investigate longitudinal changes in cognitive functions in association with AF-type (non-paroxysmal vs. paroxysmal) and comorbidities in the Swiss-AF cohort.
METHODS
Seven cognitive measures were administered up to five times between 2014 and 2022. Age-education standardized scores were calculated and association between longitudinal change in scores and baseline AF-type investigated using linear mixed-effects models. Associations between AF-type and time to cognitive drop, an observed score of at least one standard deviation below individual's age-education standardized cognitive scores at baseline, were studied using Cox proportional hazard models of each cognitive test, censoring patients at their last measurement. Models were adjusted for baseline covariates.
RESULTS
2,415 AF patients (mean age 73.2 years; 1,080 paroxysmal, 1,335 non-paroxysmal AF) participated in this Swiss multicenter prospective cohort study. Mean cognitive scores increased longitudinally (median follow-up 3.97 years). Non-paroxysmal AF patients showed smaller longitudinal increases in Digit Symbol Substitution Test (DSST), Cognitive Construct Score (CoCo)and Trail Making Test part B (TMT-B) scores vs. paroxysmal AF patients. Diabetes, history of stroke/TIA and depression were associated with worse performance on all cognitive tests. No differences in time to cognitive drop were observed between AF-types in any cognitive test.
CONCLUSION
This study indicated preserved cognitive functioning in AF patients, best explained by practice effects. Smaller practice effects were found in non-paroxysmal AF patients in the DSST, TMT-B and the CoCo and could indicate a marker of subtle cognitive decline. As diabetes, history of stroke/TIA and depression-but not AF-type-were associated with cognitive drop, more attention should be given to risk factors and underlying mechanisms of AF
Real-world cost-effectiveness of pulmonary vein isolation for atrial fibrillation: a target trial approach.
OBJECTIVES
Randomized controlled trials of pulmonary vein isolation (PVI) for treating atrial fibrillation (AF) have proven the procedure's efficacy. Studies assessing its empirical cost-effectiveness outside randomized trial settings are lacking. We aimed to evaluate the effectiveness and cost-effectiveness of PVI versus medical therapy for AF.
METHODS
We followed a target trial approach using the Swiss AF cohort, a prospective observational cohort study that enrolled AF patients between 2014 and 2017. Resource utilization and cost information was collected through claims data. Quality-of-life was measured with EQ-5D-3L utilities. We estimated incremental cost-effectiveness ratios from the perspective of the Swiss statutory health insurance system.
RESULTS
Patients undergoing PVI compared to medical therapy had a 5-year overall survival advantage with a hazard ratio of 0.75 (95%CI 0.46-1.21, p=0.69), a 19.8% standard deviation improvement in quality-of-life (95%CI 15.5-22.9%, p<0.001), at an incremental cost of 29,604 (95%CI 16,354-42,855, p<0.001) Swiss Francs (CHF). The estimated incremental cost-effectiveness ratio was CHF 158,612 per quality-adjusted life-year (QALY) gained within a 5-year time horizon. Assuming similar health effects and costs over 5 additional years changed the incremental cost-effectiveness ratio to CHF 82,195 per QALY gained. Results were robust to the sensitivity analyses performed.
CONCLUSIONS
Our results show that PVI might be a cost-effective intervention within the Swiss healthcare context in a 10-year time horizon, but unlikely to be so at 5-years, if a willingness-to-pay threshold of CHF100,000 per QALY gained is assumed. Given data availability, we find target trial designs are a valuable tool for assessing the cost-effectiveness of healthcare interventions outside of RCT settings
Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project
- âŠ